全文获取类型
收费全文 | 10735篇 |
免费 | 828篇 |
国内免费 | 987篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 76篇 |
妇产科学 | 17篇 |
基础医学 | 791篇 |
口腔科学 | 8篇 |
临床医学 | 993篇 |
内科学 | 1929篇 |
皮肤病学 | 8篇 |
神经病学 | 754篇 |
特种医学 | 274篇 |
外科学 | 1974篇 |
综合类 | 3160篇 |
现状与发展 | 1篇 |
预防医学 | 149篇 |
眼科学 | 75篇 |
药学 | 1435篇 |
1篇 | |
中国医学 | 870篇 |
肿瘤学 | 25篇 |
出版年
2024年 | 9篇 |
2023年 | 57篇 |
2022年 | 123篇 |
2021年 | 183篇 |
2020年 | 204篇 |
2019年 | 168篇 |
2018年 | 205篇 |
2017年 | 306篇 |
2016年 | 370篇 |
2015年 | 302篇 |
2014年 | 573篇 |
2013年 | 656篇 |
2012年 | 646篇 |
2011年 | 732篇 |
2010年 | 699篇 |
2009年 | 731篇 |
2008年 | 790篇 |
2007年 | 802篇 |
2006年 | 739篇 |
2005年 | 673篇 |
2004年 | 548篇 |
2003年 | 551篇 |
2002年 | 486篇 |
2001年 | 421篇 |
2000年 | 337篇 |
1999年 | 239篇 |
1998年 | 186篇 |
1997年 | 147篇 |
1996年 | 138篇 |
1995年 | 123篇 |
1994年 | 89篇 |
1993年 | 77篇 |
1992年 | 40篇 |
1991年 | 57篇 |
1990年 | 29篇 |
1989年 | 22篇 |
1988年 | 30篇 |
1987年 | 11篇 |
1986年 | 10篇 |
1985年 | 13篇 |
1984年 | 15篇 |
1982年 | 6篇 |
1981年 | 5篇 |
1980年 | 1篇 |
1977年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
《Saudi Pharmaceutical Journal》2022,30(6):669-678
BackgroundIschemia reperfusion (I/R) play an imperative role in the expansion of cardiovascular disease. Sinomenine (SM) has been exhibited to possess antioxidant, anticancer, anti-inflammatory, antiviral and anticarcinogenic properties. The aim of the study was scrutinized the cardioprotective effect of SM against I/R injury in rat.MethodsRat were randomly divided into normal control (NC), I/R control and I/R + SM (5, 10 and 20 mg/kg), respectively. Ventricular arrhythmias, body weight and heart weight were estimated. Antioxidant, inflammatory cytokines, inflammatory mediators and plasmin system indicator were accessed.ResultsPre-treated SM group rats exhibited the reduction in the duration and incidence of ventricular fibrillation, ventricular ectopic beat (VEB) and ventricular tachycardia along with suppression of arrhythmia score during the ischemia (30 and 120 min). SM treated rats significantly (P < 0.001) altered the level of antioxidant parameters. SM treatment significantly (P < 0.001) repressed the level of creatine kinase MB (CK-MB), creatine kinase (CK) and troponin I (Tnl). SM treated rats significantly (P < 0.001) repressed the tissue factor (TF), thromboxane B2 (TXB2), plasminogen activator inhibitor 1 (PAI-1) and plasma fibrinogen (Fbg) and inflammatory cytokines and inflammatory mediators.ConclusionOur result clearly indicated that SM plays anti-arrhythmia effect in I/R injury in the rats via alteration of oxidative stress and inflammatory reaction. 相似文献
2.
《药学学报(英文版)》2020,10(9):1634-1645
Systematic administration of anti-inflammatory cytokine interleukin 4 (IL-4) has been shown to improve recovery after cerebral ischemic stroke. However, whether IL-4 affects neuronal excitability and how IL-4 improves ischemic injury remain largely unknown. Here we report the neuroprotective role of endogenous IL-4 in focal cerebral ischemia–reperfusion (I/R) injury. In multi-electrode array (MEA) recordings, IL-4 reduces spontaneous firings and network activities of mouse primary cortical neurons. IL-4 mRNA and protein expressions are upregulated after I/R injury. Genetic deletion of Il-4 gene aggravates I/R injury in vivo and exacerbates oxygen-glucose deprivation (OGD) injury in cortical neurons. Conversely, supplemental IL-4 protects Il-4−/− cortical neurons against OGD injury. Mechanistically, cortical pyramidal and stellate neurons common for ischemic penumbra after I/R injury exhibit intrinsic hyperexcitability and enhanced excitatory synaptic transmissions in Il-4−/− mice. Furthermore, upregulation of Nav1.1 channel, and downregulations of KCa3.1 channel and α6 subunit of GABAA receptors are detected in the cortical tissues and primary cortical neurons from Il-4−/− mice. Taken together, our findings demonstrate that IL-4 deficiency results in neural hyperexcitability and aggravates I/R injury, thus activation of IL-4 signaling may protect the brain against the development of permanent damage and help recover from ischemic injury after stroke. 相似文献
3.
Roberto V.P. Ribeiro Mitesh V. Badiwala Danny Ramzy Laura C. Tumiati Vivek Rao 《The Journal of thoracic and cardiovascular surgery》2019,157(2):615-625.e1
Objective
Hypertonic saline (HTS) has potent immune and vascular effects. We assessed recipient pretreatment with HTS on allograft function in a porcine model of heart transplantation and hypothesized that HTS infusion would limit endothelial and left ventricular (LV) dysfunction following transplantation.Methods
Heart transplants were performed after 6 hours of cold ischemic storage. Recipient pigs were randomized to treatment with or without HTS (7.5% NaCl) before cardiopulmonary bypass (CPB). Using a myograft apparatus, coronary artery endothelial-dependent (Edep) and -independent (Eind) relaxation was assessed. LV performance was determined using pressure-volume loop analysis. Pulmonary interleukin (IL)-2, IL-6, and tumor necrosis factor (TNF)-α expression was measured.Results
Weaning from CPB and LV performance after transplantation were improved in HTS-treated animals. Successful weaning from CPB was greater in the HTS-treated hearts (8 of 8 vs 2 of 8; P < .05). Mean LV functional recovery was improved in the HTS-treated animals, as assessed by preload recruitable stroke work (65 ± 10% vs 27 ± 10%; P < .001) and end-systolic elastance (55 ± 7% vs 37 ± 4%; P < .001). Treatment with HTS resulted in improved Edep (mean maximum elastance [Emax], 56 ± 5% vs 37 ± 7%; P < .001) and Eind (mean Emax%, 77 ± 6% vs 52 ± 4%; P < .001) vasorelaxation compared with control. Pulmonary expression of IL-2, IL-6, and TNF-α increased following transplantation, whereas HTS therapy attenuated IL production (P < .001). Transplantation increased plasma TNF-α levels and LV TNF-α expression, whereas HTS prevented this up-regulation (P < .001).Conclusions
Recipient HTS pretreatment preserves allograft vasomotor and LV function, and HTS therapy limits CPB-induced injury. HTS may be a novel recipient intervention to prevent graft dysfunction. 相似文献4.
目的探讨急性心肌梗死(AMI)患者急诊经皮冠状动脉介入治疗(PCI)术后血清三碘甲状腺原氨酸(T3)与心肌再灌注的关系。方法采用化学发光法检测205例AMI患者PCI术后血清T3水平,根据T3水平将患者分为A、B、C、D4组,记录并比较4组患者术后冠状动脉TIMI血流分级、心肌呈色分级(MBG)。结果A组(重度低T3组)TIMI3级比例低于B、C、D组,差异有统计学意义(P<0.01);MBG3级比例低于B、C、D组,差异有统计学意义(P<0.01)。女性患者T3水平(1.00±0.05)nmol/L、TIMI3级比例(32/46,69.6%)、MBG3级比例(24/46,52.2%)均低于男性患者,后者分别为(1.19±0.02)nmol/L、(143/159,89.9%)、(110/159,69.2%),差异均有统计学意义(P<0.05或0.01)。结论女性AMI患者心肌再灌注水平较男性患者低。AMI患者T3水平与PCI术后冠状动脉再灌注相关,监测T3可以间接反映病情的严重程度。 相似文献
5.
经鼻给予抗ICAM-1抗体对大鼠脑缺血再灌注损伤的保护作用 总被引:1,自引:0,他引:1
目的 探讨经鼻腔给予抗细胞间黏附分子-1(ICAM-1)单克隆抗体(单抗)对大鼠脑缺血再灌注损伤的保护作用.方法 将30只雄性Wistar大鼠随机分为假手术组、脑缺血再灌注组及脑缺血再灌注+经鼻给予高、中、低剂量抗ICAM-1单抗干预组.采用插线法制作局灶脑缺血再灌注模型.各干预组于缺血1 h经鼻给予抗ICAM-1单抗,再灌24 h后取脑行冠状切片.采用TTC、HE及免疫组化染色法测定脑梗死体积及免疫组化阳性区占总面积比.结果 缺血再灌注组脑标本均可见缺血侧的脑膜充血,脑组织肿胀;单纯脑缺血再灌注组及低、中、高抗ICAM-1单抗干预组脑梗死体积(以像素值表示)分别为57 042±12 483、32 871±4 325、25 932±3 103和15 325±3 356,免疫组化阳性区面积占总面积比分别为(6.64±0.476)%、(5.15±0.987)%、(4.36±0.682)%和(3.42±0.537)%,各组间差异均有统计学意义.结论 (1)脑缺血再灌注可使脑组织ICAM-1表达显著增高;(2)经鼻腔给予抗ICAM-1单抗可有效降低脑组织ICAM-1的表达,缩小脑梗死体积;(3)经鼻腔给予抗ICAM-1单抗的剂量同脑梗死体积呈负相关;(4)脑缺血再灌注时ICAM-1免疫组化阳性区面积比与脑梗死体积呈正相关. 相似文献
6.
A. Nakao H. Toyokawa A. Tsung M. A. Nalesnik D. B. Stolz J. Kohmoto A. Ikeda K. Tomiyama T. Harada T. Takahashi R. Yang M. P. Fink K. Morita A. M. K. Choi N. Murase 《American journal of transplantation》2006,6(10):2243-2255
Carbon monoxide (CO), a byproduct of heme catalysis, was shown to have potent cytoprotective and anti-inflammatory effects. In vivo recipient CO inhalation at low concentrations prevented ischemia/reperfusion (I/R) injury associated with small intestinal transplantation (SITx). This study examined whether ex vivo delivery of CO in University of Wisconsin (UW) solution could ameliorate intestinal I/R injury. Orthotopic syngenic SITx was performed in Lewis rats after 6 h cold preservation in control UW or UW that was bubbled with CO gas (0.1-5%) (CO-UW). Recipient survival with intestinal grafts preserved in 5%, but not 0.1%, CO-UW improved to 86.7% (13/15) from 53% (9/17) with control UW. At 3 h after SITx, grafts stored in 5% CO-UW showed improved intestinal barrier function, less mucosal denudation and reduced inflammatory mediator upregulation compared to those in control UW. Preservation in CO-UW associated with reduced vascular resistance (end preservation), increased graft cyclic guanosine monophosphate levels (1 h), and improved graft blood flow (1 h). Protective effects of CO-UW were reversed by ODQ, an inhibitor of soluble guanylyl cyclase. In vitro culture experiment also showed better preservation of vascular endothelial cells with CO-UW. The study suggests that ex vivo CO delivery into UW solution would be a simple and innovative therapeutic strategy to prevent transplant-induced I/R injury. 相似文献
7.
腺苷与异丙酚预处理对犬心肌缺血再灌注损伤的保护作用 总被引:2,自引:0,他引:2
目的探讨腺苷与异丙酚预处理对犬心肌缺血再灌注损伤的保护作用。方法 21只杂种犬,雌雄不拘,随机分为3组(n=7):缺血再灌注组(A组)、异丙酚预处理组(B组)、异丙酚与腺苷联合预处理组(C组)。A组冠状动脉的左前降支结扎60min后松开结扎,再灌注:120min;B组缺血前30min经静脉以5.6mg·kg-1·h-1速率持续泵注异丙酚30min;C组缺血前10min经主动脉根部一次性注入腺苷(10mmol·L-1,10ml),其余处理同B组。记录心脏血液动力学指标,并行节段性室壁运动评分(RWMS)。结果缺血即刻出现了缺血性心电图的变化。与基础值比较,A组缺血期及再灌注期 LVEDP升高,CO、SV、LVEF、CPP、RPP降低,再灌注期MAP降低,HR减慢,B、C组上述缺血再灌注诱导的血液动力学变化减弱,A组缺血期及再灌注期RWMS增加,但B、C组缺血期RWMS低于A组(P< 0.05或0.01)。结论异丙酚预处理对犬心肌缺血再灌注损伤有一定的保护作用,腺苷预处理并未增强其保护作用。 相似文献
8.
小鼠不完全性脑缺血、再灌注时脑膜血流量的变化及尼莫地平的作用 总被引:5,自引:1,他引:4
目的:观察双侧颈总动脉阻断后脑血流的变化。方法:结扎双侧颈总动脉观察小鼠不完全性脑缺血及其再灌注时脑膜血流量的变化。结果:结扎颈总动脉后小鼠脑膜血流量在几秒钟内骤然下降,血流量较结扎前降低约85.9%±6.45%。同时血管中红细胞运动近停滞状态,血管再通时脑血流处于低灌注状态,血流量下降34.47%±11.69%,此时脑缺血再灌后脑组织实际上处于一种慢性缺血状态。再灌注10d后,小鼠脑海马CA1区神经细胞数明显减少。尼莫地平可以解除再灌注时的脑血流低灌状态。并防止由此所引起的脑海马CA1区神经细胞的缺失。结论:缺血后及时给予尼莫地平具有积极的治疗意义。 相似文献
9.
大鼠小肠缺血再灌注后血中NO,SOD浓度及肺中Bax,Bcl-2表达的改变 总被引:11,自引:4,他引:7
目的:研究大鼠小肠缺血再灌注后后血中一氧化氮(NO),超氧化物歧化酶(SOD)的浓度变化以及肺组织中Bax,Bcl-2的表达,探讨小肠缺血再灌注后对肺组织的损伤,方法:建立小肠缺血再灌注模型,分对照 ,再灌注后0,30min,1,2h,1,3,7d共8组,于各时点检测血中Bax,Bcl-2的表达情况。结果:大鼠小肠缺血再灌注后NO浓度0min明显升高,2h时降低,随后升高,7d时达高峰,SOD浓度0min明显下降,2h 时升高,随后下降,7d时达最低,Bax,Bcl-2免疫阳性细胞主要位于肺组织中血管内皮细胞和肺泡上皮细胞,再灌注0min,Bax,Bcl-2阳性细胞率增多,30min时Bax,Bcl-2阳性细胞率均升高分别为17.1%和78.1%,Bcl-2表达高于Bax,两者差别显著(P<0.01),2h时降低,其后升高,7d时阳性细胞率达高峰分别为94.1%和83.4%,Bax表达明显高于Bcl-2,两者差异显著(P<0.01)。结论:大鼠小肠缺血再灌注后可引起血中NO,SOD的浓度变化和Bax及Bcl-2阳性细胞在肺组织中的表达改变并可能引起肺组织细胞凋亡和损伤。 相似文献
10.
高位硬膜外阻滞对猪急性心肌缺血/再灌注损伤时血浆TXB2和6-keto-PGF1α水平的影响 总被引:1,自引:0,他引:1
目的探讨0.5%布比卡因高位硬膜外阻滞对急性心肌缺血/再灌注损伤时血栓素B2(TXB2)和6-酮-前列腺素F1α(6-keto-PGF1α)的影响.方法健康雄性家猪20只,体重(23.0±2.5)kg,随机分为布比卡因组(Ⅰ组)、生理盐水组(Ⅱ组).静注10mg.kg-1硫喷妥钠后,气管插管,静点琥珀胆碱和芬太尼控制呼吸,维持麻醉.T3~4穿刺置入硬膜外导管,按分组分别硬膜外注射0.5%布比卡因和生理盐水各2ml,15min后结扎左冠脉前降支40min.分别在给药前和结扎40min时、开放后1h、3h、5h抽取右心房血,测定血浆TXB2、6-keto-PGF1α的浓度.给药前所测定的心率(HR)、平均动脉压(MAP)、中心静脉压(CVP)作为基础值.结果Ⅱ组各时点血液动力学无明显变化,Ⅰ组HR、MAP和CVP分别下降22%、25%和28%.两组再灌注后1h、3h及5h TXB2、TXB2/6-keto-PGF1α比值逐渐升高,且均显著高于给药前和结扎40min.Ⅰ组升高程度显著低于Ⅱ组(P<0.05).而6-keto-PGF1α组内组间比较,变化趋势与TXB2恰相反.Ⅰ组有1只因室颤而死亡,Ⅱ组有4只(P<0.05).结论心肌缺血/再灌注损伤与TXB2和6-keto-PGF1α有一定关系,高位硬膜外阻滞通过调节缺血/再灌注后血栓素A2和前列环素的平衡在一定程度上减轻了心肌缺血/再灌注损伤. 相似文献